Viewing Study NCT00493766


Ignite Creation Date: 2025-12-24 @ 4:40 PM
Ignite Modification Date: 2026-02-21 @ 9:25 PM
Study NCT ID: NCT00493766
Status: TERMINATED
Last Update Posted: 2020-12-19
First Post: 2007-06-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety of LBH589 Alone and in Combination With IV Docetaxel and Prednisone
Sponsor: Novartis Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hormone Refractory Prostate Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None LBH589 View
None Prostate Cancer View
None HRPC View
None Hormone Refractory Prostate Cancer View